These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22354262)

  • 1. The effect of antihypertensive treatment on headache and blood pressure variability in randomized controlled trials: a systematic review.
    Webb AJ; Rothwell PM
    J Neurol; 2012 Sep; 259(9):1781-7. PubMed ID: 22354262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis.
    Webb AJ; Fischer U; Mehta Z; Rothwell PM
    Lancet; 2010 Mar; 375(9718):906-15. PubMed ID: 20226989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dose and combination of antihypertensives on interindividual blood pressure variability: a systematic review.
    Webb AJ; Rothwell PM
    Stroke; 2011 Oct; 42(10):2860-5. PubMed ID: 21817143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers for hypertension.
    Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of β-blocker selectivity on blood pressure variability and stroke: a systematic review.
    Webb AJ; Fischer U; Rothwell PM
    Neurology; 2011 Aug; 77(8):731-7. PubMed ID: 21795649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke.
    Rothwell PM; Howard SC; Dolan E; O'Brien E; Dobson JE; Dahlöf B; Poulter NR; Sever PS;
    Lancet Neurol; 2010 May; 9(5):469-80. PubMed ID: 20227347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive drugs for acute stroke.
    Blood pressure in Acute Stroke Collaboration (BASC)
    Cochrane Database Syst Rev; 2000; (4):CD002839. PubMed ID: 11034772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in left ventricular geometry during antihypertensive treatment.
    Salvetti M; Paini A; Bertacchini F; Stassaldi D; Aggiusti C; Agabiti Rosei C; Bassetti D; Agabiti-Rosei E; Muiesan ML
    Pharmacol Res; 2018 Aug; 134():193-199. PubMed ID: 29959031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 - effects of different classes of antihypertensive drugs in older and younger patients: overview and meta-analysis.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2018 Aug; 36(8):1637-1647. PubMed ID: 29847487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Anti-Hypertensive Therapy and Stroke Prevention: A Meta-Analysis.
    Mukete BN; Cassidy M; Ferdinand KC; Le Jemtel TH
    Am J Cardiovasc Drugs; 2015 Aug; 15(4):243-57. PubMed ID: 26055616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials.
    Shahin Y; Khan JA; Chetter I
    Atherosclerosis; 2012 Mar; 221(1):18-33. PubMed ID: 22209214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure variability and risk of new-onset atrial fibrillation: a systematic review of randomized trials of antihypertensive drugs.
    Webb AJ; Rothwell PM
    Stroke; 2010 Sep; 41(9):2091-3. PubMed ID: 20651263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003.
    Staessen JA; Wang JG; Thijs L
    J Hypertens; 2003 Jun; 21(6):1055-76. PubMed ID: 12777939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium channel blockers versus other classes of drugs for hypertension.
    Chen N; Zhou M; Yang M; Guo J; Zhu C; Yang J; Wang Y; Yang X; He L
    Cochrane Database Syst Rev; 2010 Aug; (8):CD003654. PubMed ID: 20687074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.